- Home
- Software
- usa massachusetts
- breast cancer
Show results for
Refine by
Breast Cancer Software In Massachusetts
6 software items found
by:Aiforia Technologies based inCambridge, MASSACHUSETTS (USA)
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. Automatically scores the ER positive and negative cells of epithelial origin from either WSI or selected image areas, saving the pathologist time. Provides intelligent ...
by:Aiforia Technologies based inCambridge, MASSACHUSETTS (USA)
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. Automatically scores the PR positive and negative cells of epithelial origin from either WSI or selected image areas, saving the pathologist time. Provides intelligent ...
by:Aiforia Technologies based inCambridge, MASSACHUSETTS (USA)
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. utomatically scores the Ki67 positive and negative cells of epithelial origin from either WSI or selected image areas, saving the pathologist time. Provides ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
PathExploreTM offers unprecedented spatial and cellular resolution of the tumor microenvironment (TME) from H&E images. PathExplore is an AI-powered panel of histopathology features that spatially characterize the tumor microenvironment (TME) with single-cell ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer.1 Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop inherited cancer depends on the ability to characterize genes ...